XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2020 $ 192 $ 1,372,083 $ 85 $ (1,036,869) $ 335,491
Balance, shares at Dec. 31, 2020 192,294        
Net (loss) income       (111,894) (111,894)
Other comprehensive income (loss)     (58)   (58)
Issuance of common stock in conjunction with equity plans $ 9 30,113     30,122
Issuance of common stock in conjunction with equity plans, shares 8,126        
Issuance of common stock in Private Placement, net of issuance costs $ 11 294,834     294,845
Issuance of common stock in Private Placement, net of issuance costs, Shares 11,215        
Issuance of common stock in acquisition of Omniome $ 9 237,875     237,884
Issuance of common stock in acquisition of Omniome, shares 8,912        
Stock-based compensation expense   54,417     54,417
Balance at Sep. 30, 2021 $ 221 1,989,322 27 (1,148,763) 840,807
Balance, shares at Sep. 30, 2021 220,547        
Balance at Jun. 30, 2021 $ 199 1,423,357 (6) (1,165,305) 258,245
Balance, shares at Jun. 30, 2021 198,917        
Net (loss) income       16,542 16,542
Other comprehensive income (loss)     33   33
Issuance of common stock in conjunction with equity plans $ 2 4,809     4,811
Issuance of common stock in conjunction with equity plans, shares 1,503        
Issuance of common stock in Private Placement, net of issuance costs $ 11 294,834     294,845
Issuance of common stock in Private Placement, net of issuance costs, Shares 11,215        
Issuance of common stock in acquisition of Omniome $ 9 237,875     237,884
Issuance of common stock in acquisition of Omniome, shares 8,912        
Stock-based compensation expense   28,447     28,447
Balance at Sep. 30, 2021 $ 221 1,989,322 27 (1,148,763) 840,807
Balance, shares at Sep. 30, 2021 220,547        
Balance at Dec. 31, 2021 $ 221 2,009,945 (1,087) (1,218,092) $ 790,987
Balance, shares at Dec. 31, 2021 220,978       220,978
Net (loss) income       (229,864) $ (229,864)
Other comprehensive income (loss)     (5,173)   (5,173)
Issuance of common stock in conjunction with equity plans $ 5 9,978     9,983
Issuance of common stock in conjunction with equity plans, shares 4,938        
Stock-based compensation expense   60,658     60,658
Balance at Sep. 30, 2022 $ 226 2,080,581 (6,260) (1,447,956) $ 626,591
Balance, shares at Sep. 30, 2022 225,916       225,916
Balance at Jun. 30, 2022 $ 225 2,058,103 (5,457) (1,370,985) $ 681,886
Balance, shares at Jun. 30, 2022 224,756        
Net (loss) income       (76,971) (76,971)
Other comprehensive income (loss)     (803)   (803)
Issuance of common stock in conjunction with equity plans $ 1 3,542     3,543
Issuance of common stock in conjunction with equity plans, shares 1,160        
Stock-based compensation expense   18,936     18,936
Balance at Sep. 30, 2022 $ 226 $ 2,080,581 $ (6,260) $ (1,447,956) $ 626,591
Balance, shares at Sep. 30, 2022 225,916       225,916